In recent years, progress has been made in the pathogenesis and clinical treatment of NKTCL [5], the treatment regimens containing asparaginase have better effects on NKTCL, such as the SMILE regimen, AspaMetDex regimen, IMEP-L-asp regimen, P-GEMOX regimen, and DDGP regimen [6]. This evidence concerns the gene ASPG and extranodal nasal NK/T cell lymphoma.